KLRS
Kalaris Therapeutics, Inc. Common Stock
KLRS
KLRS
75 hedge funds and large institutions have $600M invested in Kalaris Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 10 reducing their positions, and 10 closing their positions.
Holders
75
Holders Change
+4
Holders Change %
+5.63%
% of All Funds
1.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
38
Reduced
10
Closed
10
Calls
$5.24M
Puts
$44K
Net Calls
+$5.2M
Net Calls Change
+$5.18M
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$36.6M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$51.1M |
| 3 |
3
BlackRock
New York
|
$55.5M |
| 4 |
4
JPMorgan Chase & Co
New York
|
$11.7M |
| 5 |
5
Goldman Sachs
New York
|
$6.56M |
